The Associated Medical Schools of New York (AMSNY) brings you the following compilation of the most recent updates and news on research from the academic medical centers in the state.
Highlights
Cancer
- Discovery May Lead to Targeted Melanoma Therapies
- Weill Cornell Investigators Discover How Ovarian Halts Body’s Natural Defense Against Tumor
- University at Buffalo Researchers to Further Test Promising Anti-Cancer Antibody
Cardiology
- Scientists Discover New Powerful Drug Candidate Can Improve a Failing Heart’s Function
- Study Finds Lipid Mediator Associated with Good Cholesterol Promotes More Than Just Good Heart Health
Genetics
- Mount Sinai Scientists Develop New Technique for Analyzing the Epigenetics of Bacteria, a Potential New Tool to Combat Pathogens and Overcome Antibiotic Resistance
- ‘Think Like Pathogens’ to Fight Infection
Neurology
Other Studies
- Food Order Has Significant Impact on Glucose and Insulin Levels
- Cognitive Behavioral Therapy Most Consistent Treatment for Panic Disorders
- Acid-Reducing Medications Sharply Raise Risk of C. Diff. Bacteria Infection in Kids
- Study of Physician Participation in Electronic Health Record Incentive Programs Signals Need for Further EHR Healthcare Policy Maintenance
- Pelvic Organic Prolapse Procedures with Mesh Increase, Leading to Age-based Complications
- New Color Blindness Cause Identified
Other Articles of Interest
- Albany Medical Board of Directors Welcomes Three New Members
- Ceremony Marks Investiture of Mark Taubman as Medical Center CEO
- Hundreds of New Health Professional Graduate from SUNY Downstate Medical Center
Researchers at the Academic Medical Centers
Funds for Research
Discovery May Lead to Targeted Melanoma Therapies
Weill Cornell Investigators Discover How Ovarian Cancer Halts Body’s Natural Defense Against Tumor
June 11, 2015 – Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells’ disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.
University at Buffalo Researchers to Further Test Promising Anti-Cancer Antibody
June 8, 2015 – For-Robin, a company founded and led by a Kate Rittenhouse-Olson, PhD, will further study and develop a promising potential cancer treatment. The next steps in the research and development process will be funded with a $2 million grant from the National Cancer Institute (NCI).
© 2015 School of Medicine and Biomedical Sciences at the University at Buffalo. All rights reserved.
Scientists Discover New Powerful Drug Candidate Can Improve a Failing Heart’s Function
Study Finds Lipid Mediator Associated with Good Cholesterol Promotes More Than Just Good Heart Health
June 8, 2015 – High-density lipoprotein (HDL) is often referred to as “good” cholesterol because it transports fat molecules out of blood vessels, protecting against stroke and heart disease. Now, researchers at Weill Cornell Medical College have discovered that HDL in blood also carries a protein that powerfully regulates immune function. Together they play an important role in preventing inflammation in the body.
Mount Sinai Scientists Develop New Technique for Analyzing the Epigenetics of Bacteria, a Potential New Tool to Combat Pathogens and Overcome Antiobiotic Resistance
‘Think Like Pathogens’ to Fight Infection
June 10, 2015 – In the fight against infectious disease, University at Buffalo immunologist Michael W. Russell, PhD, professor of microbiology and immunology, advocates a novel alternative to antibiotics and vaccines: directly target the immune system.
© 2015 School of Medicine and Biomedical Sciences at the University at Buffalo. All rights reserved.
Commentary: Hospice Services Can Better Promote Bereavement for Spousal Caregivers
givers after their loved ones have died, Weill Cornell Medical College researchers write in a commentary published May 26 in JAMA Internal Medicine.
Food Order Has Significant Impact on Glucose and Insulin Levels
Take a closer look.
© 2015 Weill Cornell Medical College. All rights reserved.
Cognitive Behavioral Therapy Most Consistent Treatment for Panic Disorders
Acid-Reducing Medications Sharply Raise Risk of C. Diff. Bacteria Infection in Kids
June 17, 2015 – Infants and children who are given prescription acid-reducing medications face a substantially higher risk of developing Clostridium difficile infection, a potentially severe colonic disorder. The findings, reported by Columbia University Medical Center (CUMC) researchers, suggest that pediatricians may do more harm than good by prescribing these drugs for children who have non-specific gastrointestinal symptoms such as occasional vomiting. The study was published recently in the online edition of Clinical Infectious Diseases.
Study of Physician Participation in Electronic Health Record Incentive Programs Signals Need for Further EHR Healthcare Policy Maintenance
June 8, 2015 – Federal programs offering financial incentives to physicians who adopt electronic health record systems have boosted the number of participants who use them, Weill Cornell Medical College researchers found in a new study. But in the process, systematic differences have emerged between physicians who consistently participated in the programs and those who did not, which could lead to disparities in patient care.
Pelvic Organic Prolapse Procedures with Mesh Increase, Leading to Age-based Complications
June 2, 2015 – Despite FDA warnings that a synthetic mesh used to treat a weakening of the female pelvis’s walls can cause infection, pain, and disease recurrence, surgeons are increasing their use of the device. What’s more, when compared to not using mesh, younger patients who undergo surgery with mesh for pelvic organ prolapse (POP) are more likely to have a repeat surgery the following year, and older patients are more likely to have complications while they’re in the hospital, according to new research from Weill Cornell Medical College.
New Color Blindness Cause Identified
June 1, 2015 – A rare eye disorder marked by color blindness, light sensitivity, and other vision problems can result from a newly discovered gene mutation identified by an international research team, including scientists from Columbia University Medical Center (CUMC). The findings, which were published today in the online edition of Nature Genetics, could lead to new, targeted treatments for this form of color blindness.
Albany Medical Board of Directors Welcomes Three New Members
June 22, 2015 – Albany Medical Center today announced the appointment of three distinguished local leaders and philanthropists to its Board of Directors: Dr. Robert J. Jones, president of the University at Albany, Ruth Mahoney, president of KeyBank’s Capital Region Market, and Morris Carl Massry (“Murray”), project manager at Tri City Rentals.
Ceremony Marks Investiture of Mark Taubman as Medical Center CEO
June 12, 2015 – Mark B. Taubman, M.D., was formally invested as the Chief Executive Officer of the University of Rochester Medical Center and UR Medicine and Senior Vice President for Health Sciences at the University of Rochester at a ceremony on Wednesday, June 10, in the medical school’s Class of ’62 Auditorium.
Hundreds of New Health Professionals Graduate from SUNY Downstate Medical Center
June 5, 2015 – SUNY Downstate Medical Center graduated a new class of physicians, nurses, allied health professionals, research scientists, and public health professionals at commencement ceremonies held recently at Carnegie Hall.